Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Sadler

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Pharmacotherapy|December 22, 1999
Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy menR E Polk, M A Crouch, D S Israel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1992
Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humansC E Cook, A R Jeffcoat, B M Sadler, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virus type 1 protease inhibitor, in subjects with normal or impaired hepatic functionL Veronese, J Rautaureau, B M Sadler, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 9, 1998
Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malariaA Sabchareon, P Attanath, P Phanuaksook, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2001
Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy malesR E Polk, D F Brophy, D S Israel, et al.
Journal of Clinical Pharmacology|April 18, 2001
Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjectsB M Sadler, G E Chittick, R E Polk, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Pharmacotherapy|December 22, 1999
Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy menR E Polk, M A Crouch, D S Israel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1992
Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humansC E Cook, A R Jeffcoat, B M Sadler, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virus type 1 protease inhibitor, in subjects with normal or impaired hepatic functionL Veronese, J Rautaureau, B M Sadler, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 9, 1998
Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malariaA Sabchareon, P Attanath, P Phanuaksook, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2001
Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy malesR E Polk, D F Brophy, D S Israel, et al.
Journal of Clinical Pharmacology|April 18, 2001
Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjectsB M Sadler, G E Chittick, R E Polk, et al.
Pageof 3